Sort
15,273 grants matching “antimicrobial resistance”
POINT OF CARE DIAGNOSTIC FOR GONORRHEA AND DETERMINATION OF ANTIMICROBIAL SUSCEPTIBILITY
$299,652Season Wong · Ai Biosciences, Inc. · N43 · FY2019 · AI
THERAPY AGAINST RECALCITRANT C. albicans INFECTION
$299,643Thomas A Dahl · Arietis · R43 · FY2008 · AI
AstraDx: Sub-Hour AST Via Computational Image Processing
$299,633Jonathan Florez · Astradx, Inc. · R43 · FY2022 · AI
Lab-on-a-Film Multiplexed Test for Respiratory Mycobacterial Infections
$299,610Christopher Gerard Cooney · Akonni Biosystems, Inc. · R43 · FY2021 · AI
Development of Peptide Antibiotic Nucleic Acids
$299,600Dev Priya Arya · Nubad, Llc · R41 · FY2015 · AI
THERAPY AGAINST RECALCITRANT C. albicans INFECTION
$299,600Thomas A Dahl · Arietis · R43 · FY2009 · AI
Drug Discovery from Slow Growing and Rare Microbial Species
$299,559Amy Lynn Spoering · Novobiotic Pharmaceuticals, Llc · R43 · FY2011 · AI
Bioorganic Approaches Toward Novel Antimicrobial Agents Against Gram-Negative Bacteria
$299,528Steven D. Townsend · Vanderbilt University · R35 · FY2023 · GM
Bioorganic Approaches Toward Novel Antimicrobial Agents Against Gram-Negative Bacteria
$299,528Steven D. Townsend · Vanderbilt University · R35 · FY2021 · GM
Bioorganic Approaches Toward Novel Antimicrobial Agents Against Gram-Negative Bacteria
$299,528Steven D. Townsend · Vanderbilt University · R35 · FY2022 · GM
COMBATING MULTI-DRUG RESISTANT BACTERIA
$299,524Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2010 · GM
COMBATING MULTI-DRUG RESISTANT BACTERIA
$299,524Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2009 · GM
Susceptibility Testing, Treatment Choices, and Outcomes of MDR-GNB Infections
$299,510Lisa L. Maragakis · Johns Hopkins University · R01 · FY2008 · CI
Antibiotic discovery from a new genus of uncultured bacteria.
$299,505Amy Lynn Spoering · Novobiotic Pharmaceuticals, Llc · R43 · FY2020 · AI
Combining benchmarking and Competency-based training to implement antimicrobial stewardship on dairy farms
$299,466Pamela L Ruegg · Michigan State University · U01 · FY2023 · FD
POLYAMINE METABOLISM OF CRYPTOSPORIDIA:RATIONAL THERAPY
$299,449Pace University New York · R01 · FY2001 · AI
Inhibitors of T3SS translocon assembly to combat multi-drug resistant P. aeruginosa
$299,449Donald T Moir · Microbiotix, Inc · R41 · FY2020 · AI
Novel, bio-inspired chloramine to treat cutaneous fungal infections without resistance generation potential
$299,435Marc D. Hein · Halomine, Inc. · R43 · FY2025 · AI
Tethered liquid perfluorocarbon coating for preventing urinary catheter colonization
$299,429Todd McFarland · Cerulean Scientific Inc. · R43 · FY2022 · DK
Drug Discovery from Slow Growing and Rare Microbial Species
$299,417Amy Lynn Spoering · Novobiotic Pharmaceuticals, Llc · R43 · FY2010 · AI
GLYCOPEPTIDE COMPLEXES WITH BACTERIAL CELL WALLS BY REDOR NMR
$299,388Jacob Schaefer · Washington University · R01 · FY2013 · EB
Molecular analysis of accurate ribosomal translocation
$299,364Kurt L Fredrick · Ohio State University · R01 · FY2012 · GM
Susceptibility Testing, Treatment Choices, and Outcomes of MDR-GNB Infections
$299,323Lisa L. Maragakis · Johns Hopkins University · R01 · FY2007 · CI
** AWARDS ISSUED PRIOR TO JANUARY 20, 2025, WERE FUNDED UNDER PREVIOUS ADMINISTRATIONS AND MAY NOT REFLECT THE PRIORITIES AND POLICIES OF THE CURRENT ADMINISTRATION.** ANTIMICROBIAL USE (AMU) IN FOOD ANIMALS IS A CONTRIBUTOR TO ANTIMICROBIAL RESISTANCE (AMR) GLOBALLY. THE EFFECTS OF AMU REDUCTION IN ANIMAL PRODUCTION AND WELFARE, FOOD SAFETY, AND ENVIRONMENTAL AMR MITIGATION ARE POORLY UNDERSTOOD. THE OBJECTIVE OF THIS PROPOSAL IS TO DETERMINE THE IMPACT OF AMU ON MICROBIAL DIVERSITY, PREVALENCE OF AMR GENES, AND GENES INVOLVED IN HORIZONTAL GENE TRANSFER IN ENVIRONMENTAL SAMPLES FROM ANTIMICROBIAL-FREE AND CONVENTIONAL (I.E., FARMS THAT USE ANTIMICROBIALS AS PROPHYLACTICS) FARMS. WE WILL ALSO COMPARE BIRD MORBIDITY AND MORTALITY BETWEEN THESE TWO CATEGORIES AND IDENTIFY FACTORS THAT CONTRIBUTE TO HEALTH AND DISEASE PREVENTION. THIS INFORMATION WILL BE USED TO INFORM PRODUCERS OF IMPORTANT FACTORS CONTRIBUTING TO AMR AND HOW TO CONTROL IT. IT WILL ALSO INFORM THE SOURCES OF AMR TRANSMISSION FROM OUTSIDE TO INSIDE POULTRY HOUSES AND HOW TO IMPROVE BIOSECURITY TO AVOID THESE EVENTS. OUR SPECIFIC OBJECTIVES ARE TO (1) IDENTIFY POPULATION DIVERSITY AND PREVALENCE OF AMR GENES IN ENVIRONMENTAL SAMPLES FROM BROILER, BREEDER, AND PULLET FARMS AND HATCHERIES USING METAGENOMIC APPROACHES; (2) IDENTIFY TRANSMISSION PATHWAYS OF AMR GENES BETWEEN SAMPLE TYPES AND LOCATION INSIDE AND OUTSIDE THE POULTRY HOUSE AND BETWEEN HOUSES; (3) IDENTIFY THE IMPACT OF AMU AND FARM PRACTICES ON MICROBIOME CONNECTIONS AND TRANSMISSION OF AMR GENES. THIS RESEARCH WILL INFORM BEST PRACTICES TO REDUCE AMU WITHOUT COMPROMISING ANIMAL HEALTH AND PRODUCTIVITY. MITIGATING AMR IN POULTRY FARMS WILL IMPROVE FOOD SAFETY IN THE USA BY AVOIDING FARM-TO-FORK TRANSMISSION OF AMR PATHOGENS AND IMPROVING FOOD PRODUCTION EFFICIENCY BY REDUCING RECALLS.
$299,322Auburn University · · FY2024 · National Institute of Food and Agriculture
Collaborative Research: IIBR: Innovation: Bioinformatics: Linking Chemical and Biological Space: Deep Learning and Experimentation for Property-Controlled Molecule Generation
$299,320Amarda Shehu · George Mason University · · FY2023 · BIO